Micro-RNA may amplify effectiveness of sorafenib in difficult liver cancer cases

Go to article

Posted by on February 17, 2017 8:23 pm
Tags:
Categories: health

Only 25% of patients respond to sorafenib treatment, so researchers have endeavored to understand its mechanism of action and discover a way to boost its effectiveness.

Leave a Reply

Your email address will not be published. Required fields are marked *

< Buzz Post home